HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Na Lu Selected Research

Dextran Sulfate

1/2019LL202 ameliorates colitis against oxidative stress of macrophage by activation of the Nrf2/HO-1 pathway.
9/2016LL202 protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting MAPK/AP-1 signaling.
6/2016Wogonoside prevents colitis-associated colorectal carcinogenesis and colon cancer progression in inflammation-related microenvironment via inhibiting NF-κB activation through PI3K/Akt pathway.
9/2015GL-V9, a new synthetic flavonoid derivative, ameliorates DSS-induced colitis against oxidative stress by up-regulating Trx-1 expression via activation of AMPK/FOXO3a pathway.
3/2015Wogonoside protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB and NLRP3 inflammasome activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Na Lu Research Topics

Disease

119Neoplasms (Cancer)
05/2024 - 04/2007
34Breast Neoplasms (Breast Cancer)
12/2022 - 07/2008
27Inflammation (Inflammations)
05/2024 - 05/2009
24Hepatocellular Carcinoma (Hepatoma)
08/2023 - 11/2008
20Neoplasm Metastasis (Metastasis)
01/2024 - 07/2008
16Gout
04/2024 - 07/2015
11Hypoxia (Hypoxemia)
06/2023 - 05/2013
10Pain (Aches)
07/2022 - 01/2013
10Carcinoma (Carcinomatosis)
10/2020 - 04/2008
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2023 - 09/2007
8Colitis
01/2021 - 03/2015
7Colonic Neoplasms (Colon Cancer)
01/2024 - 08/2012
7Atopic Dermatitis (Atopic Eczema)
12/2023 - 06/2021
7Osteoarthritis
01/2023 - 10/2015
7Colorectal Neoplasms (Colorectal Cancer)
11/2022 - 06/2011
7Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2021 - 03/2015
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 05/2013
7Leukemia
10/2018 - 04/2012
6Infections
01/2020 - 03/2008
6Hypersensitivity (Allergy)
01/2019 - 11/2015
5Type 2 Diabetes Mellitus (MODY)
04/2024 - 10/2012
5Hypertension (High Blood Pressure)
11/2023 - 05/2017
5Hyperuricemia
11/2023 - 12/2015
5Stomach Neoplasms (Stomach Cancer)
12/2022 - 02/2009
5Venous Thromboembolism
11/2022 - 01/2016
5Body Weight (Weight, Body)
11/2020 - 03/2015
5Melanoma (Melanoma, Malignant)
05/2015 - 07/2008
5Ischemia
09/2014 - 12/2007
4Sepsis (Septicemia)
05/2024 - 07/2023
4Necrosis
12/2023 - 08/2013
4COVID-19
12/2023 - 01/2023
4Myocardial Infarction
10/2023 - 06/2012
4Insulin Resistance
05/2023 - 05/2009
4Reperfusion Injury
12/2022 - 12/2007
4Glioblastoma (Glioblastoma Multiforme)
10/2022 - 03/2008
4Glioma (Gliomas)
10/2022 - 03/2008
4Esophageal Squamous Cell Carcinoma
09/2020 - 01/2012
4Vasculitis (Vasculitides)
12/2018 - 12/2016
4Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
01/2018 - 06/2016
3Wounds and Injuries (Trauma)
05/2024 - 09/2014
3Asthma (Bronchial Asthma)
01/2024 - 12/2019
3Fibrosis (Cirrhosis)
12/2023 - 01/2015
3Neuroblastoma
12/2023 - 03/2014
3Lung Neoplasms (Lung Cancer)
12/2023 - 05/2014
3Hypertriglyceridemic Waist
05/2023 - 01/2019
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2023 - 04/2009

Drug/Important Bio-Agent (IBA)

37FlavonoidsIBA
06/2023 - 05/2009
275,7- dihydroxy- 6- methoxy- 2- phenylchromen- 4- oneIBA
01/2021 - 11/2008
24wogoninIBA
10/2020 - 04/2007
19gambogic acidIBA
04/2017 - 03/2008
18Proteins (Proteins, Gene)FDA Link
05/2024 - 12/2007
13Uric Acid (Urate)IBA
04/2024 - 03/2016
13Glucose (Dextrose)FDA LinkGeneric
04/2024 - 06/2013
10wogonosideIBA
10/2019 - 05/2009
8Reactive Oxygen Species (Oxygen Radicals)IBA
02/2024 - 06/2009
7CytokinesIBA
05/2024 - 10/2014
7baricitinibIBA
12/2023 - 06/2021
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2023 - 04/2008
6LipopolysaccharidesIBA
05/2024 - 01/2013
6Biomarkers (Surrogate Marker)IBA
02/2022 - 05/2014
6Messenger RNA (mRNA)IBA
02/2020 - 12/2011
6LYG 202IBA
01/2018 - 08/2009
5salicylhydroxamic acid (SHAM)IBA
02/2024 - 12/2007
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2024 - 11/2012
5GlucocorticoidsIBA
01/2024 - 01/2017
5InflammasomesIBA
12/2023 - 03/2015
5Small Interfering RNA (siRNA)IBA
12/2023 - 10/2008
5Doxorubicin (Adriamycin)FDA LinkGeneric
12/2023 - 10/2010
5Lactic Acid (Lactate)FDA LinkGeneric
06/2023 - 06/2015
5Tramadol (K315)FDA LinkGeneric
11/2022 - 12/2019
5DiureticsIBA
03/2022 - 05/2017
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022 - 07/2015
5Phosphotransferases (Kinase)IBA
01/2021 - 10/2013
5Allopurinol (Remid)FDA LinkGeneric
09/2019 - 07/2015
5Dextran SulfateIBA
01/2019 - 03/2015
5Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
12/2018 - 06/2016
5Antineoplastic Agents (Antineoplastics)IBA
01/2016 - 03/2012
5Matrix Metalloproteinases (MMPs)IBA
01/2016 - 12/2008
5Matrix Metalloproteinase 2 (Gelatinase A)IBA
05/2012 - 08/2008
4Interleukin-6 (Interleukin 6)IBA
02/2024 - 10/2014
4Adenosine Triphosphate (ATP)IBA
02/2024 - 09/2014
4Triglycerides (Triacylglycerol)IBA
01/2024 - 01/2017
4EnzymesIBA
06/2023 - 02/2009
4Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
11/2022 - 01/2016
4Codeine (Codeine Phosphate)FDA LinkGeneric
11/2022 - 12/2019
4CateninsIBA
10/2020 - 10/2013
4PiperazineIBA
01/2018 - 06/2011
4Annexin A5IBA
03/2014 - 11/2008
3Long Noncoding RNAIBA
05/2024 - 05/2021
3AntioxidantsIBA
05/2024 - 03/2016
3Neuroprotective AgentsIBA
05/2024 - 12/2007
3SodiumIBA
04/2024 - 05/2017
3Peptides (Polypeptides)IBA
02/2024 - 11/2022
3Adrenal Cortex Hormones (Corticosteroids)IBA
12/2023 - 01/2022

Therapy/Procedure

31Therapeutics
04/2024 - 03/2008
7Radiotherapy
06/2023 - 04/2009
5Drug Therapy (Chemotherapy)
04/2024 - 07/2013
5Aftercare (After-Treatment)
11/2023 - 11/2012
4Dietary Approaches To Stop Hypertension
01/2023 - 05/2017
3Ligation
05/2024 - 10/2016